3 reasons telehealth is here to stay – MedCity News
The question isn’t if telemedicine has a future, but rather how ubiquitous it will be in our healthcare system moving forward.
The question isn’t if telemedicine has a future, but rather how ubiquitous it will be in our healthcare system moving forward.
A new survey revealed that 64% of clinicians feel physically unsafe at work. The perceived risk of violence was especially high among women, clinicians under…
Pfizer and Flagship Pioneering are partnering in a drug research alliance leveraging the capabilities of the more than 40 biotech startups in the venture capital…
The at-home care field holds significant market potential. As the subsector continues to grow, some leaders of home healthcare startups are challenging misconceptions that some…
KFF found that the 10 top-selling Part D drugs represented $47.7 billion of the $215.7 billion total gross Medicare Part D drug spending in 2021.…
Quantum Health has bolstered its collaboration with Sword Health by integrating MSK services to members to track home exercise, avoid unnecessary surgery and support treatment…
NYU researchers conducted a study this year in which nearly 400 people were asked to identify whether responses to patient questions were produced by human…
AstraZeneca and Sanofi drug Beyfortus is now FDA approved for preventing respiratory problems from RSV infection in infants and toddlers. Antibody engineering enables the drug…
Prominence Health Medicare Advantage enrollees will have 24/7 access to Strive Health’s specialized care team through a new partnership. Strive Health is also teaming up…
Kraft Heinz recently sued Aetna, claiming that the insurer is not providing all of Kraft Heinz’s medical claims data. More lawsuits of this sort are…
Alzheimer’s disease patients in the earliest stages of their disease benefited the most benefit from Eli Lilly drug donanemab, which is expected to receive an…